PHASE II STUDY OF LCL161, A SMAC MIMETIC, IN PATIENTS WITH PRIMARY MYELOFIBROSIS (PMF), POST-POLYCYTHEMIA VERA MYELOFIBROSIS (POST-PV MF) OR POST-ESSENTIAL THROMBOCYTOSIS MYELOFIBROSIS (POST-ET MF
EHA Library, Naveen Pemmaraju,
133287
OUTCOMES AFTER AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION (SCT) IN DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) PATIENTS WITH MYC/BCL2 CO-EXPRESSION, DOUBLE-HIT LYMPHOMA, OR MYC COPY GAIN
EHA Library, Alex F. Herrera,
133327
PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF GBT440, A NOVEL HEMOGLOBIN S (HBS) POLYMERIZATION INHIBITOR FOR THE TREATMENT OF SICKLE CELL DISEASE (SCD), IN HEALTHY VOLUNTEERS AND SCD PATIENTS
EHA Library, Mira Pochron,
133357
MULTICENTER, PROSPECTIVE, RANDOMIZED TRIAL OF INTRAVENOUS ITRACONAZOLE VS. LIPOSOMAL AMPHOTERICIN B AS EMPIRICAL ANTIFUNGAL THERAPY FOR HEMATOLOGICAL MALIGNANCY WITH PERSISTENT FEVER AND NEUTROPENIA
EHA Library, Isao Yoshida,
133365
DETERMINING EFFECTS OF PLATELET INHIBITION ON VASO-OCCLUSIVE EVENTS (DOVE) TRIAL: A DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY OF PRASUGREL IN PAEDIATRIC PATIENTS WITH SICKLE CELL ANAEMIA
EHA Library, Matthew Heeney,
133387
ROMIPLOSTIM IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
EHA Library, Michael Tarantino,
133388